American Heart Association Feature
American Heart Association Alumni Feature - Cardiovascular Disease and Biomedical Engineering at Purdue/Indiana University
NIH R01 funded to help children with muscular dystrophy
NIH provides funding to the CVIRL to improve prediction of heart disease progression in pediatric patients with Duchenne muscular dystrophy
International experience highlighted in Fulbright Chronicles
Fulbright experiences by Katherine Kerr and Craig Goergen are described in this Fulbright Chronicles article.
NIH Maternal Health Diagnostics Challenge - Honorable Mention for Purdue!
The National Institutes of Health today announced the winners of its NIH Technology Accelerator Challenge (NTAC) for Maternal Health, a prize competition for developers of diagnostic technologies to help improve maternal health around the world.
Hunting for early biomarkers of Duchenne muscular dystrophy
Engineering and medicine combined to track early biomarkers of cardiomyopathy (CM) in patients with Duchenne muscular dystrophy
The Purdue CardioVascular Imaging Research Laboratory
The mission of the Purdue University Cardiovascular Imaging Research Laboratory (CVIRL) is to advance imaging techniques to study disease progression and improve detection and treatment across a broad spectrum of medical conditions, ultimately enhancing the quality of human life. Under the guidance of Dr. Craig Goergen, we have previously been focused on developing imaging techniques to study both cardiac and vascular disease, but current efforts take a more expansive approach, including research projects from cancer to diabetes. Non-invasive imaging aids our group in the development of technologies that will positively impact the clinical care of patients.
As part of the Weldon School of Biomedical Engineering at Purdue University, we are working with collaborators in the College of Engineering, the College of Health and Human Sciences, the College of Veterinary Medicine, the Indiana University School of Medicine, and others to conduct translational research. Our overall aim is to advance the field of imaging to help diagnose, treat, or prevent disease, ultimately providing patients with longer and more fulfilling lives.